163 related articles for article (PubMed ID: 17135308)
1. Heterozygous beta-globin gene mutations as a risk factor for iron accumulation and liver fibrosis in chronic hepatitis C.
Sartori M; Andorno S; Pagliarulo M; Rigamonti C; Bozzola C; Pergolini P; Rolla R; Suno A; Boldorini R; Bellomo G; Albano E
Gut; 2007 May; 56(5):693-8. PubMed ID: 17135308
[TBL] [Abstract][Full Text] [Related]
2. Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C.
Geier A; Reugels M; Weiskirchen R; Wasmuth HE; Dietrich CG; Siewert E; Gartung C; Lorenzen J; Bosserhoff AK; Brügmann M; Gressner AM; Matern S; Lammert F
Liver Int; 2004 Aug; 24(4):285-94. PubMed ID: 15287851
[TBL] [Abstract][Full Text] [Related]
3. Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype.
Gehrke SG; Stremmel W; Mathes I; Riedel HD; Bents K; Kallinowski B
J Mol Med (Berl); 2003 Dec; 81(12):780-7. PubMed ID: 14557859
[TBL] [Abstract][Full Text] [Related]
4. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
[TBL] [Abstract][Full Text] [Related]
5. Iron overload and HFE gene mutations in Polish patients with liver cirrhosis.
Sikorska K; Romanowski T; Stalke P; Iżycka-Świeszewska E; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):270-5. PubMed ID: 21669570
[TBL] [Abstract][Full Text] [Related]
6. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis.
Valenti L; Pulixi EA; Arosio P; Cremonesi L; Biasiotto G; Dongiovanni P; Maggioni M; Fargion S; Fracanzani AL
Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859
[TBL] [Abstract][Full Text] [Related]
7. Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
Holmström P; Marmur J; Eggertsen G; Gåfvels M; Stål P
Gut; 2002 Nov; 51(5):723-30. PubMed ID: 12377814
[TBL] [Abstract][Full Text] [Related]
8. Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver disease.
Valenti L; Canavesi E; Galmozzi E; Dongiovanni P; Rametta R; Maggioni P; Maggioni M; Fracanzani AL; Fargion S
J Hepatol; 2010 Nov; 53(5):927-33. PubMed ID: 20739079
[TBL] [Abstract][Full Text] [Related]
9. HFE genotype, parenchymal iron accumulation, and liver fibrosis in patients with nonalcoholic fatty liver disease.
Valenti L; Fracanzani AL; Bugianesi E; Dongiovanni P; Galmozzi E; Vanni E; Canavesi E; Lattuada E; Roviaro G; Marchesini G; Fargion S
Gastroenterology; 2010 Mar; 138(3):905-12. PubMed ID: 19931264
[TBL] [Abstract][Full Text] [Related]
10. Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
Cheng R; Barton JC; Morrison ED; Phatak PD; Krawitt EL; Gordon SC; Kowdley KV
J Clin Gastroenterol; 2009 Jul; 43(6):569-73. PubMed ID: 19359997
[TBL] [Abstract][Full Text] [Related]
11. Hepatic iron overload in patients with chronic viral hepatitis: role of HFE gene mutations.
Piperno A; Vergani A; Malosio I; Parma L; Fossati L; Ricci A; Bovo G; Boari G; Mancia G
Hepatology; 1998 Oct; 28(4):1105-9. PubMed ID: 9755249
[TBL] [Abstract][Full Text] [Related]
12. The relation of iron status and hemochromatosis gene mutations in patients with chronic hepatitis C.
Kazemi-Shirazi L; Datz C; Maier-Dobersberger T; Kaserer K; Hackl F; Polli C; Steindl PE; Penner E; Ferenci P
Gastroenterology; 1999 Jan; 116(1):127-34. PubMed ID: 9869610
[TBL] [Abstract][Full Text] [Related]
13. Iron overload and HFE gene mutations in Czech patients with chronic liver diseases.
Dostalikova-Cimburova M; Kratka K; Stransky J; Putova I; Cieslarova B; Horak J
Dis Markers; 2012; 32(1):65-72. PubMed ID: 22297603
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of primary iron overload and common HFE gene mutations with liver cirrhosis in adult Indian population.
Jain S; Agarwal S; Tamhankar P; Verma P; Choudhuri G
Indian J Gastroenterol; 2011 Jul; 30(4):161-5. PubMed ID: 21822737
[TBL] [Abstract][Full Text] [Related]
15. The role of iron overload and HFE gene mutations in the era of pegylated interferon and ribavirin treatment of chronic hepatitis C.
Sikorska K; Stalke P; Izycka-Swieszewska E; Romanowski T; Bielawski KP
Med Sci Monit; 2010 Mar; 16(3):CR137-143. PubMed ID: 20190684
[TBL] [Abstract][Full Text] [Related]
16. Liver steatosis correlates with iron overload but not with HFE gene mutations in chronic hepatitis C.
Sikorska K; Stalke P; Romanowski T; Rzepko R; Bielawski KP
Hepatobiliary Pancreat Dis Int; 2013 Aug; 12(4):377-84. PubMed ID: 23924495
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of HFE mutations in Japanese patients with chronic hepatitis C.
Ishizu Y; Katano Y; Honda T; Hayashi K; Ishigami M; Itoh A; Hirooka Y; Nakano I; Goto H
J Gastroenterol Hepatol; 2012 Jun; 27(6):1112-6. PubMed ID: 22098610
[TBL] [Abstract][Full Text] [Related]
18. HFE mutations, hepatic iron, and fibrosis: ethnic-specific association of NASH with C282Y but not with fibrotic severity.
Chitturi S; Weltman M; Farrell GC; McDonald D; Kench J; Liddle C; Samarasinghe D; Lin R; Abeygunasekera S; George J
Hepatology; 2002 Jul; 36(1):142-9. PubMed ID: 12085358
[TBL] [Abstract][Full Text] [Related]
19. Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C.
Bonkovsky HL; Troy N; McNeal K; Banner BF; Sharma A; Obando J; Mehta S; Koff RS; Liu Q; Hsieh CC
J Hepatol; 2002 Dec; 37(6):848-54. PubMed ID: 12445428
[TBL] [Abstract][Full Text] [Related]
20. The effect of the metabolic syndrome, hepatic steatosis and steatohepatitis on liver fibrosis in hereditary hemochromatosis.
Adams LA; Angulo P; Abraham SC; Torgerson H; Brandhagen D
Liver Int; 2006 Apr; 26(3):298-304. PubMed ID: 16584391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
